StockWatch
·

Genpharmasec Ltd Q3 FY25 Results

GENPHARMAQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue8.4840.6%
Total Income9.3037.1%
Expenditure8.0027.5%
PBT1.29155.8%
Net Profit0.7810.8%
OPM2.64%12.78pp
NPM8.39%1.99pp
EPS0.010.0%
View full financials

Informational and educational content only. Not investment advice.